SCHEMBL4635362

SCHEMBL4635362

NC(=O)NC1(Cc2ccc(F)cc2)CCN(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.40
DPP4 P27487 1/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 1/20 0.38
ADRB2 P07550 2/20 0.37
HTT P42858 1/20 0.36
FAAH O00519 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
POLB P06746 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5807513 0.87 HTT (0.41) HSD11B1DPP4CNR2ALDH1A1SMN1; SMN2
SCHEMBL4634991 0.84 HSD11B1 (0.41) HSD11B1CNR2ALDH1A1SMN1; SMN2FAAH
SCHEMBL5674700 0.82 HDAC2 (0.46) CNR2MEN1KMT2A
Hydrochloric Acid SCHEMBL5810883 0.78 HSD11B1 (0.43) HSD11B1ALDH1A1POLB
SCHEMBL4634537 0.77 CYP46A1 (0.50) HSD11B1OPRD1OPRK1
SCHEMBL4634933 0.75 OPRD1 (0.40) ALDH1A1OPRD1MEN1KMT2A
SCHEMBL4635001 0.73 CCR1 (0.57) SMN1; SMN2LMNAHTT
SCHEMBL2798597 0.73 ALDH1A1 (0.43) HSD11B1ALDH1A1POLB
SCHEMBL4634716 0.73 HSD11B1 (0.41) HSD11B1ALDH1A1FAAHPOLBKMT2A
SCHEMBL4634337 0.71 OPRM1 (0.43) HSD11B1OPRD1OPRK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928829-A1 PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE CC CHEMOKINE RECEPTOR CCR1 AND THEIR USE AS ANTI-INFLAMMATORY AGENTS Schering Aktiengesellschaft (DE) 2008-06-11 EP disclosed
WO-2006066948-A1 PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE CC CHEMOKINE RECEPTOR CCR1 AND THEIR USE AS ANTI-INFLAMMATORY AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-29 WO disclosed